🏢 What the Company Does
Colgate-Palmolive (NYSE: CL) is a global consumer staples company best known for its oral care, personal care, home care, and pet nutrition products. The company operates in more than 200 countries and territories and owns globally recognized brands including Colgate, Palmolive, and Hill’s Pet Nutrition.
Its business benefits from recurring demand because consumers regularly purchase products such as toothpaste, soap, dishwashing liquid, and pet food, making revenue relatively stable across economic cycles.
📊 Financial Highlights
- Net sales reached a record $20.4 billion in FY2025.
- Gross margin remained above 60%, supported by pricing and productivity improvements.
- Operating income and EPS declined mainly because of a $919 million non-cash goodwill and intangible asset impairment charge.
- Operating cash flow increased to $4.2 billion, allowing the company to continue investing in the business while returning capital to shareholders.
- The company continued paying dividends and repurchasing shares throughout the year.
⚠️ Key Risks
- Intense competition from global consumer products companies and private-label brands.
- Changing consumer preferences and the need for continuous product innovation.
- Supply chain disruptions and fluctuations in raw material costs.
- Cybersecurity risks affecting global operations and information systems.
- Execution risks related to expanding Hill’s Pet Nutrition and integrating acquisitions.
- Regulatory compliance, sustainability commitments, and protection of valuable global brands.
📈 MD&A Highlights
Management stated that revenue growth during FY2025 was driven primarily by higher pricing, premium products, and acquisitions, while foreign exchange and softer organic volume partially offset growth.
Although reported earnings declined because of the impairment charge, management emphasized that the underlying business remained resilient, supported by strong gross margins, record operating cash flow, continued productivity initiatives, and ongoing investment in brands, manufacturing, digital capabilities, and Hill’s Pet Nutrition.
✅ Takeaway
FY2025 demonstrated that Colgate-Palmolive’s core consumer products business remained stable despite lower reported earnings. Record revenue, strong cash generation, disciplined capital allocation, and continued investment in global brands reflected the company’s long-term strategy, while the impairment charge primarily affected accounting results rather than everyday business operations.
💵 Income Statement Summary
Unit: $m, EPS in $
| (unit: $m, EPS in $) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | 19,457 | 20,101 | 20,382 |
| Cost of Goods Sold | 8,131 | 7,940 | 8,131 |
| Gross Profit | 11,326 | 12,161 | 12,251 |
| SG&A | 7,151 | 7,729 | 7,903 |
| Operating Income | 3,984 | 4,268 | 3,306 |
| Non-Operating Income/Expense | (191) | (164) | (123) |
| Interest Income/Expense | (232) | (225) | (192) |
| Income Before Tax | 3,392 | 3,956 | 3,059 |
| Income Tax | 937 | 907 | 798 |
| Net Income | 2,300 | 2,889 | 2,132 |
| EPS | 2.8 | 3.5 | 2.6 |
Plain English
Colgate-Palmolive continued to grow its business in FY2025, with net sales increasing to $20.4 billion, marking another year of record revenue. Revenue growth slowed compared with FY2024, but the company still expanded sales despite operating in a mature consumer staples industry.
Gross profit reached a record $12.3 billion. Although cost of goods sold increased slightly from the prior year, pricing actions and product mix continued to support healthy gross profitability. This indicates that the company largely maintained its ability to pass higher costs on to customers through pricing rather than absorbing them entirely.
The biggest change in FY2025 occurred below the gross profit line. Operating income declined from $4.3 billion to $3.3 billion, primarily because the company recognized approximately $919 million of goodwill and intangible asset impairment charges. An impairment charge is an accounting adjustment that reduces the carrying value of assets when management believes those assets are worth less than previously recorded. While it lowers reported earnings, it does not represent a normal cash operating expense.
As a result, income before tax, net income, and EPS all declined in FY2025 after reaching multi-year highs in FY2024. Diluted EPS fell from $3.5 to $2.6, reflecting the impact of the impairment rather than deterioration in the company’s underlying consumer products business.
Another encouraging trend is that non-operating expenses continued to improve. Other expense declined from $191 million in FY2023 to $123 million in FY2025, while net interest expense also improved modestly as interest income increased and interest expense gradually declined.
Overall, the income statement suggests that Colgate-Palmolive’s core operations remained resilient, but FY2025 reported earnings were temporarily reduced by a large one-time accounting impairment rather than broad weakness in everyday consumer demand.
📊 Key Financial Ratios
Unit: % (except Net Debt / EBITDA and Interest Coverage Ratio, which are shown in x)
| Ratio | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| ROE (%) | 240.3% | 531.1% | 584.1% |
| ROA (%) | 14.0% | 18.0% | 13.1% |
| ROTC (%) | 43.2% | 54.4% | 39.9% |
| ROIC (%) | 49.4% | 61.6% | 44.6% |
| Gross Margin (%) | 58.2% | 60.5% | 60.1% |
| Operating Margin (%) | 20.5% | 21.2% | 16.2% |
| Pretax Margin (%) | 17.4% | 19.7% | 15.0% |
| Net Margin (%) | 11.8% | 14.4% | 10.5% |
| Debt-to-Equity Ratio (D/E) (%) | 891.0% | 1,461.2% | 2,188.5% |
| Net Debt / EBITDA (x) | 1.8x | 1.5x | 1.6x |
| Interest Coverage Ratio (x) | 17.2x | 19.0x | 17.2x |
| Current Ratio (%) | 111.3% | 92.3% | 83.3% |
| Quick Ratio (%) | 70.5% | 57.8% | 53.7% |
| Fixed Asset to Long-term Capital Ratio (%) | 51.9% | 58.9% | 67.4% |
Plain English
Colgate-Palmolive continued to generate strong profitability in FY2025 despite reporting lower earnings because of the large goodwill impairment charge. Gross margin remained above 60% for the second consecutive year, showing that the company continues to benefit from strong pricing power and premium brands. Even after the impairment, a gross margin above 60% is exceptionally strong for a global consumer staples company.
The decline in operating margin, pretax margin, and net margin was largely driven by the non-cash impairment charge rather than weaker product demand. Excluding this one-time accounting adjustment, the underlying profitability of the business remained relatively stable compared with prior years.
ROTC (Return on Total Capital) and ROIC (Return on Invested Capital) also declined in FY2025 because operating income fell after the impairment. However, both ratios remained well above levels that many analysts consider indicative of a high-quality business, reflecting Colgate-Palmolive’s ability to generate attractive returns from the capital invested in its operations.
The company’s reported ROE appears unusually high, exceeding 500% in FY2024 and FY2025. This should not be interpreted as extraordinary operating performance. Instead, Colgate-Palmolive has maintained an extremely small book equity balance for many years because of substantial share repurchases. As treasury stock accumulates on the balance sheet, reported shareholders’ equity becomes very small, mathematically inflating ROE. For this reason, investors often rely more heavily on ROIC and ROTC when evaluating the company’s long-term operating performance.
Leverage remained manageable despite the high Debt-to-Equity ratio. The D/E ratio looks exceptionally high because shareholders’ equity is close to zero rather than because debt has expanded dramatically. A better measure is Net Debt / EBITDA, which stayed around 1.5x–1.8x over the past three years, indicating that debt remains well supported by operating cash generation.
Liquidity ratios gradually declined over the three-year period, with both the current ratio and quick ratio falling below 1.0. While this might appear concerning for many businesses, it is relatively common among mature consumer staples companies with highly predictable cash flows and efficient working capital management.
Overall, the ratio analysis shows that Colgate-Palmolive’s underlying business quality remained strong. The primary reason profitability metrics weakened in FY2025 was a one-time impairment charge rather than deterioration in the company’s competitive position or recurring cash-generating ability.
📝 Disclaimer
This article is intended for educational purposes only. It does not constitute financial, investment, or legal advice. All investment decisions involve risks, and readers should conduct their own research or consult with a licensed financial advisor.
👉 Colgate-Palmolive Company (CL) FY2025 10-K Analysis (Filed 2026) | Explained for Beginners
Originally published on Finvincio